Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQT | ISIN: DK0061155009 | Ticker-Symbol:
1-Jahres-Chart
PHARMA EQUITY GROUP A/S Chart 1 Jahr
5-Tage-Chart
PHARMA EQUITY GROUP A/S 5-Tage-Chart

Aktuelle News zur PHARMA EQUITY GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.11.Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 202461Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November...
► Artikel lesen
23.10.Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.62Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement...
► Artikel lesen
14.10.Major shareholder announcement - Pharma Equity Group A/S1
14.10.Pharma Equity Group A/S: Managers' transactions1
11.10.Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue215The share capital of Pharma Equity Group A/S has been increased. The admittance to trading and official listing of new shares will take effect as per 16 October 2024 in the ISIN below. ISIN ...
► Artikel lesen
11.10.Pharma Equity Group A/S: Pharma Equity Group announces successful completion of directed issue of new shares3
PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln
04.10.Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share158The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024. ISIN DK0061155009 -------------------------------------------------------------------------------- Name:...
► Artikel lesen
04.10.Pharma Equity Group A/S: Pharma Equity Group announces issuance of new shares in a direct issue2
04.10.Pharma Equity Group A/S: Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights1
16.08.Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2024118Consolidated Interim Report 1 January - 30 June 2024 Company announcement no. 23 - August 16, 2024 Key points from the H1-2024 report (period 1 January - 30 June 2024) On 16 August 2024, the...
► Artikel lesen
16.07.Pharma Equity Group A/S: The Board of Directors' decision to issue convertible loans1
15.07.Major shareholder announcement - Pharma Equity Group A/S1
03.06.Results of extraordinary general meeting in Pharma Equity Group A/S148Results of extraordinary general meeting in Pharma Equity Group A/S 3 June 2024Company announcement no. 19Pharma Equity Group A/S today held an extraordinary general meeting with the following...
► Artikel lesen
16.05.Pharma Equity Group A/S: Consolidated interim report 1 January - 31 March 2024136Consolidated interim report 1 January - 31 March 2024 Company announcement no. 17 Date: 16 May 2024 Key points from Q1-24 report (period 1 January - 31 March 2024) On 16 May 2024, the Board of...
► Artikel lesen
05.04.Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented drug candidate RNX-051.1505 April 2024 Company Announcement No. 11 Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented...
► Artikel lesen
22.03.Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009122Date: 22 March 2024 Announcement of the Year No. 9 Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009...
► Artikel lesen
20.03.Pharma Equity Group A/S - Annual Report 2023 142Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual report 2023 - main features of the year Today, the Board of Directors...
► Artikel lesen
05.03.Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds182Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for...
► Artikel lesen
22.01.Pharma Equity Group A/S: Notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters of colorectal cancer through intraluminal application (RNX-051).202Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1